“viking-global-investors” Archives

in
Entry Author Date Location
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies 08/26/20 San Francisco
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut 06/27/19 San Francisco
Inhibrx, Fresh Off $40M Funding to Advance Cancer Drugs, Eyes IPO 06/03/19 San Diego
Inhibrix Pulls In $40M to Press Ahead With Cancer Drug Clinical Trials 05/24/19 San Diego
Ginkgo’s Motif Launches with $90M for Animal-Free Meat & Milk Proteins 02/26/19 Boston
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Genomatica Grabs $90M to Boost Sustainable Chemical Business 10/05/18 San Diego
On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels In $90M 09/05/18 San Francisco
Blockchain Tomatoes & Edible Peels: Startups Innovate to Fight Spoilage 08/06/18 National
Moderna, Still Private, Scoops Up Yet Another $500M 02/01/18 Boston
Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars 12/14/17 Boston
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
How Bayer and Ginkgo Teamed Up in a $100M Synthetic Biology Bet 09/18/17 Boston
Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups 07/26/17 San Francisco
Trace Genomics Lands $4,000,000 New Funding 07/15/16 San Francisco
Ginkgo Gulps $100M to Build Synthetic Food, Fragrance Business 06/08/16 Boston
Ginkgo Bioworks Receives $100,000,000 Series C Round 06/08/16 Boston
Vitagene Obtains $5,500,000 Seed Round 02/17/16 San Francisco
Impossible Foods Lands $108,000,000 Series D Funding 10/07/15 San Francisco
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
Editas Medicine Garners $120,000,000 New Funding 08/10/15 Boston
Illumina Announces Three New Companies for Genomics Accelerator 08/05/15 San Francisco
Ginkgo Bioworks Garners $45,000,000 New Funding 07/23/15 Boston
Page 1 of 2 next page »